Search
Sunday 14 June 2015
  • :
  • :
Latest Update

Friday’s Trade News Alert on: Gol Linhas Aereas Inteligentes (NYSE:GOL), CIT Group (NYSE:CIT), Advaxis, (NASDAQ:ADXS), Republic Services, (NYSE:RSG)

On Friday, Gol Linhas Aereas Inteligentes SA (ADR) (NYSE:GOL)’s shares inclined 1.62% to $2.51.

Gol Linhas Aereas Inteligentes SA (ADR) (GOL) declared the formation of a 50/50 joint venture with Stolt-Nielsen Limited to pursue opportunities in small-scale LNG production and distribution. Stolt-Nielsen has also made a planned investment in Golar through open market purchases, representing an ownership stake of about 2.3%.

The joint venture between Golar and Stolt-Nielsen will draw upon the logistics and small-scale LNG assets controlled by Stolt-Nielsen and the ocean-based LNG midstream assets controlled by Golar to provide a fully integrated LNG logistics service to consumers of natural gas.

Gol Linhas Aéreas Inteligentes S.A. provides regular and non-regular air transportation services for passengers, cargoes, and mailbags in Brazil and internationally. The company operates in two segments, Flight Transportation and Smiles Loyalty Program. As of December 31, 2014, it operated a fleet of 144 aircraft, which comprised of 96 aircraft under operating leases, 45 aircraft under finance leases, and 3 aircraft owned by the company.

CIT Group Inc. (NYSE:CIT)’s shares dropped -0.30% to $47.28.

CIT Group Inc. (CIT) declared that CIT Corporate Finance, Healthcare offered a $29.5 million senior secured credit facility to Real Properties Health Facilities Corp. (RPHF), that will be used to consolidate existing real estate debt and for working capital purposes. RPHF operates 12 skilled nursing and assisted living facilities with about 1,000 accessible beds in Indiana, Kansas, Montana and Wisconsin. Lancaster Pollard, a specialty healthcare investment bank, advised RPHF as its placement agent for the financing. Financing was offered by CIT Bank, the U.S. commercial bank partner of CIT.

CIT Group Inc. operates as the holding company for CIT bank that provides commercial financing and leasing products; and a suite of savings options in the United States. Its Transportation & International Finance segment offers leasing and financing solutions to operators and suppliers in the aviation and railcar industries. It offers aircraft leasing, lending, asset administration, and advisory services to airlines; and term loans, leases, pre-delivery financing, fractional share financing, and vendor/manufacturer financing for corporate and private owners of business jets.

At the end of Friday’s trade, Advaxis, Inc. (NASDAQ:ADXS)‘s shares dipped -2.78% to $23.78.

Advaxis, Inc. (ADXS) declared that it has designated Fred J. Frullo as Vice President, Regulatory Affairs. With more than 20 years of experience in the biopharmaceutical industry, Mr. Frullo is well versed in the development of global regulatory strategies for the supervision, review and assembly of pharmaceutical product submission and coordination with global health authorities to obtain approvals.

As Vice President, Regulatory Affairs, Mr. Frullo will oversee regulatory submissions for the company’s Lm-LLO cancer immunotherapy clinical programs, counting ADXS-HPV, ADXS-PSA and ADXS-HER2, in addition to combination studies involving complementary immunotherapy technologies. Mr. Frullo will lead the development and submission of all regulatory documents on behalf of Advaxis to the appropriate health agencies and coordinating joint submissions with Advaxis’s planned partners as warranted. In this role, Mr. Frullo will succeed Ms. Chris L. French, MBA, who will now lead the company’s compliance program.

Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. The Lm-LLO immunotherapy platform technology stimulates the immune system to induce antigen-specific anti-tumor immune responses involving innate and adaptive arms of the immune system by inhibiting the T-cells, tregs, and myeloid-derived suppressor cells, and MDSC to promote immunologic tolerance of cancer cells in the tumor. Its lead product ADXS-HPV, an Lm-LLO immunotherapy product candidate used for the treatment of human papilloma virus (HPV) associated cancers, accomplished its Phase II study.

Republic Services, Inc. (NYSE:RSG), ended its Friday’s trading session with -0.61% loss, and closed at $40.43.

Republic Services, Inc. (RSG) declared that 22-year commercial collection driver Todd Colarusso received the prestigious Driver of the Year award, given by the National Waste & Recycling Association. Driver of the Year award winners are celebrated for their exemplary customer service and safety records. The 2015 award recipients were honored this morning in Las Vegas at WasteExpo, North America’s largest annual industry tradeshow.

Republic Services, Inc., together with its auxiliaries, provides non-hazardous solid waste collection, transfer, recycling, and disposal services for commercial, industrial, municipal, and residential customers in the United States. It operates through three segments: East, Central, and West.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.

 




Leave a Reply

Your email address will not be published. Required fields are marked *